Nattokinase is the enzyme supplement where activity verification is non-negotiable.
Nattokinase has moved from Japanese functional food curiosity into a mainstream cardiovascular supplement category in the US over the past decade. The driver is the enzyme's documented fibrinolytic activity — its measurable ability to break down fibrin, the protein involved in blood clot formation — and the substantial Japanese and international research record supporting cardiovascular structure/function applications.
What makes nattokinase manufacturing different from most ingredient categories is that potency is measured by functional activity (FU — fibrinolytic units) rather than by mass. Two nattokinase supplements with the same milligram label can have wildly different actual activity if one supplier's enzyme is degraded or under-concentrated. Reputable brands declare FU activity directly on the label, and reputable manufacturers verify that activity via third-party assay on every batch. Sun's nattokinase program is built around FU verification — both on incoming raw material and on finished product.
Nattokinase formulation approaches
2,000 FU per capsule (standard)
The dominant commercial format. 2,000 fibrinolytic units per capsule, taken once or twice daily, fits the broad cardiovascular-support market. Vitamin K2 removed during purification — appropriate for the typical consumer including those on anticoagulant medication who need to avoid K2 interactions.
4,000 FU per capsule (high-potency)
Higher-activity capsules for brands positioning at the premium or practitioner-channel tier. Same purification standards, double the FU activity per serving. Used where consumers want a single-capsule daily dose at clinical activity levels.
Multi-active cardiovascular stacks
Multi-ingredient formulations pairing nattokinase with serrapeptase (broader proteolytic enzyme blend), CoQ10 (cardiovascular energy + circulation), garlic extract (traditional cardiovascular positioning), or L-arginine (nitric oxide and circulation). Enzyme activity is preserved through careful co-active selection and blend conditions; activity verified post-blend.
Private label nattokinase
Pre-developed nattokinase capsule formulations available for fast launches. Standard configuration: 2,000 FU per capsule from vitamin-K2-removed nattokinase, HPMC shell, 60-count bottles. Label under your brand and ship in 6 to 8 weeks from order confirmation.
Production specifications
| MOQ | 5,000 units |
|---|---|
| Source | Bacillus subtilis var. natto fermentation; vitamin K2 removed during purification (anticoagulant-safe) |
| Standard configurations | 2,000 FU per capsule (standard); 4,000 FU per capsule (high-potency) |
| Capsule shells | Gelatin (bovine/porcine), HPMC (vegetarian), pullulan (vegan-certifiable; oxygen barrier benefit for enzyme stability) |
| Capsule sizes | Size 1 or size 0 depending on FU loading and excipient configuration |
| Bottle packaging | 30-count, 60-count, 90-count, 120-count HDPE or PET |
| Testing per batch | FU activity assay (third-party lab), identity verification, microbial safety panel, vitamin K2 verification |
| FU activity verification | Mandatory — both on incoming raw material and on finished product |
| Lead time | 6–8 weeks from formula approval and component arrival |
The nattokinase manufacturing process
- Discovery call. Target FU activity per capsule, capsule shell, bottle configuration, co-actives (if multi-ingredient), MOQ, timeline. Written quote within one business day.
- Raw material qualification. Every incoming nattokinase lot tested for FU activity by third-party fibrinolytic assay, vitamin K2 status, microbial safety, and identity. Failing lots are rejected.
- Formula review or development. Locked formula → component costing. New brief → formulators develop the blend (FU target, shell, co-actives, fillers) and produce bench samples.
- Sample approval. Production-representative samples with verified FU activity. Review, sign off, lock the formula.
- Component procurement. Nattokinase raw material, capsule shells, bottles, labels sourced in parallel.
- Production. Encapsulation and bottling under full cGMP batch documentation. Process conditions designed to preserve enzyme activity through fill.
- Third-party testing. Every batch sampled for FU activity (the critical post-fill verification), identity, microbial safety. COA issued before shipment.
- Packaging and labeling. Bottles labeled and case-packed. FNSKU labeling for Amazon programs in-house.
- Fulfillment. Direct to your warehouse, Amazon FBA inbound, or to consumers and retailers through Sun's integrated fulfillment operation.
Who contracts nattokinase manufacturing with Sun
- Cardiovascular brands launching or extending heart-health product lines anchored by nattokinase as the foundational SKU
- Practitioner-channel brands producing high-FU clinical-positioning nattokinase for functional medicine dispensaries
- Established cardiovascular operators consolidating manufacturing for nattokinase + serrapeptase + CoQ10 multi-active formulations
- Senior-wellness DTC brands targeting the 55+ cardiovascular demographic with verified-activity nattokinase
- Amazon-native cardiovascular operators needing FU activity documentation for marketplace compliance and listing credibility
Compliance and label claims for nattokinase
Nattokinase supplements are produced and labeled under FDA's structure/function framework. Permissible label language describes how the ingredient supports normal physiological function — examples include "supports healthy circulation," "promotes cardiovascular wellness," "maintains healthy blood flow." Claims that imply disease treatment, cure, or prevention — particularly framing around blood clots, stroke risk, or heart attack prevention — fall outside the structure/function lane and create immediate regulatory risk.
Nattokinase's fibrinolytic activity is well-documented in research literature, but translating that mechanism into permissible label claims requires discipline. The temptation to reach toward stronger cardiovascular claims is real and the consequence is FDA enforcement risk. Label copy is reviewed for compliance before any production commitment. Specific claim strategy is your decision with your regulatory counsel.
Frequently asked questions
What is the minimum order quantity for nattokinase manufacturing?
Our standard MOQ for nattokinase capsule programs is 5,000 units. Contact us with your target FU activity per capsule, capsule shell, and packaging configuration — we return a written quote within one business day, including a recommendation on standardization tier.
How is nattokinase potency measured?
Nattokinase potency is measured in fibrinolytic units (FU) — a functional assay measuring the enzyme's actual activity in dissolving fibrin clots. This is meaningfully different from mass-based measurement: 100mg of nattokinase from one source may carry vastly different FU activity than 100mg from another. Reputable nattokinase supplements declare FU activity per capsule, not just milligrams. Common label declarations: 2,000 FU per capsule (standard) and 4,000 FU per capsule (high-potency). Sun verifies FU activity by third-party lab assay on every incoming raw material lot and every finished batch.
What is the raw material source?
Nattokinase is produced through fermentation of Bacillus subtilis var. natto (the same bacterium used to make traditional Japanese natto food). The fermentation extract is then purified to remove vitamin K2 (significant for consumers on anticoagulant medications), concentrated, and standardized to FU activity. We source from established suppliers with documented standardization and verify activity on every incoming lot.
Is your nattokinase vitamin K2 removed?
Yes. Standard commercial nattokinase used for cardiovascular supplementation has vitamin K2 removed during purification — this is important for consumers taking anticoagulant medications (warfarin and similar), where vitamin K2 would interact with the anticoagulant therapy. Vitamin-K2-removed nattokinase is the supplement-grade standard. We verify K2 removal status on raw material specification documentation; let us know during the discovery call if you specifically need K2-containing nattokinase for a different positioning.
What capsule shell materials are available?
Nattokinase capsules are produced in gelatin (bovine or porcine), HPMC (plant-derived, vegetarian), and pullulan (plant-derived, vegan-certifiable). HPMC and pullulan have a small additional benefit for enzyme supplements: better oxygen barrier properties help preserve enzyme activity through shelf life. We typically recommend HPMC or pullulan for nattokinase programs unless price point is the dominant constraint.
Can nattokinase be formulated with other cardiovascular actives?
Yes. Common multi-ingredient cardiovascular formulations include nattokinase plus serrapeptase (broader proteolytic enzyme stack), nattokinase plus CoQ10 (cardiovascular energy + circulation), nattokinase plus garlic extract (traditional cardiovascular support), and nattokinase plus L-arginine (circulation and nitric oxide). Co-active compatibility — particularly preservation of enzyme activity — is reviewed during the formulation phase. Blend uniformity verified before fill.
What is the lead time for nattokinase manufacturing?
Typical lead time is 6 to 8 weeks from formula approval and component arrival to finished, COA-released goods. Nattokinase sourcing is well-established but more concentrated than commodity ingredient supply chains — we factor this into procurement timelines. Repeat orders on locked formulas move faster.
What structure/function claims work for nattokinase labels?
Permissible structure/function language describes how the ingredient supports normal physiological function — typical claims include 'supports healthy circulation,' 'promotes cardiovascular wellness,' 'maintains healthy blood flow.' Claims that imply disease treatment or prevention — particularly any framing around blood clots, stroke prevention, or heart attack risk — fall outside the structure/function lane. We review label copy for compliance before any production commitment. Specific claim strategy is your decision with your regulatory counsel.